semaglutide compulsive behavior The Ozempic Era and Eating Disorders — Baltimore Therapy Group Most people think GLP-1s only

Kathryn Berlacher is a graduate of The Ohio State University College of Medicine and completed her internal medicine residency, chief residency, and cardiology fellowship at UPMC, where she has been on faculty since 2012

Side effects should also be reported to Novo Nordisk Limited (Telephone Novo Nordisk Customer Care Centre 0800 023 2573)

The polypeptide drugs, liraglutide and semaglutide, are analogs of human glucagon-like peptide-1, GLP-1 (7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37), and stimulate insulin secretion and inhibit glucagon release, thereby lowering blood glucose levels (6,7)

The 20% reduction in cardiovascular events seen in the SELECT trial may not be entirely explained by weight loss